Aim of the present work was to investigate the clinical efficacy of
Kuntai capsule in the treatment of postmenopausal women with
endometriosis,
Breast pain and
Vaginal Bleeding. 120 elderly female outpatients over 50 years old with
Breast pain were randomly divided into control group (60 cases) and observation group (60 cases). All patients were given
diclofenac sodium enteric-coated tablets 25mg, 3 times a day. The observation group was given additional Kuntai capsules at a dose of 4 capsules per time, 3 times a day. Serum
estradiol (E2),
follicle stimulating hormone (FSH), and
luteinizing hormone (LH) were detected in all patients before and at 12 weeks
after treatment. Modified Kupperman score (K score) for evaluating menopausal symptoms. The post therapeutic serum
follicle-stimulating hormone (FSH),
luteinizing hormone (LH) and
estradiol (E2) level and endometrial thickness decreased significantly (p<0.05).
After treatment, KMI scores of kunati group was significantly decreased compared with baseline (<0.01) and there was no significant difference between groups (p>0.05).
After treatment, hot flush and
insomnia scores were both improved significantly. After
therapy, serum E2 level obviously higher than the control groups, while FSH and LH levels were obviously lower (p<0.05). The incidence of
vaginal bleeding, breast distending
pain in group was obviously higher in control group than Kuntai group. Thus,
Kuntai capsule improved the ovarian function of patients, raised the level of
estrogen in vivo and alleviates the clinical manifestations of
Breast pain.